Rehospitalization, Treatment, and Resource Use After Inpatient Admission for Achalasia in the USA.

摘要: INTRODUCTION Readmission for achalasia treatment is associated with significant morbidity and cost. Factors predictive of readmission would be useful in identifying patients at risk. METHODS We performed a retrospective study using the Nationwide Database year 2016 2017. collected data on hospital readmissions 17,848 adults who were hospitalized discharged. The 30-day rate as well primary cause, mortality rate, in-hospital adverse events, total hospitalization charges examined. A cox multivariate regression model was used to identify independent risk factors readmission, including surgical or endoscopic during index admission. RESULTS From 2017, admission 15.2%. Of these 15.2%, 34% readmitted persistent symptoms treatment-related complications. Older age, higher comorbidity index, possessing private insurance, those either pneumatic balloon dilation no endoscopic/surgical showed odds analysis. Those treated laparoscopic Heller myotomy (LHM) peroral (POEM) lower readmission. There difference rates between undergoing POEM LHM, but significantly LHM group. length stay (p < 0.01) than admissions. CONCLUSION Three 20 admitted are likely within 30 days their initial hospitalization, number which can untreated multiple comorbidities. Rehospitalizations bear present burden healthcare system.